ArticlePLoS pathogens2022

A bivalent CMV vaccine formulated with human compatible TLR9 agonist CpG1018 elicits potent cellular and humoral immunity in HLA expressing mice.

Vijayendra Dasari et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.